Bone disease biobank launches to uncover hidden clues
NCT ID NCT06444503
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is creating a collection of blood, urine, and leftover surgical tissue from 350 patients with bone, calcium, and growth plate disorders. The goal is to better understand how these diseases progress and to find markers that could predict outcomes. No new treatments are being tested; instead, the samples will be used for future research.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this research could identify markers that predict disease progression and point toward new treatment targets for bone and growth plate disorders.
- What could go wrong
- This is an observational collection study, not a treatment trial. It is early-stage research, and findings may not directly lead to new therapies or benefit participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 350 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2024
- Expected to finish
-
Sep 2034
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients with with growth plate or bone pathology.
- Ages
-
Up to 99 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Children (from birth) with growth plate or bone pathology * Patients affiliated to or benefiting from a social security scheme * Patients able to receive information about the study and to understand the information form in order to participate in the study. This implies : * mastery of the French language * Not being subject to a restriction of rights by the judicial authorities * Patients or legal representatives having given their consent to participate in the study (expression of non-opposition). Exclusion Criteria: * Patients under legal protection (guardianship, curatorship or safeguard of justice) * Pregnant or breast-feeding women
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bone disorder are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University Toulouse Hospital
RECRUITINGToulouse, 31000, France